Hypothalamic CaMKKβ mediates glucagon anorectic effect and its diet-induced resistance

Molecular Metabolism

Volumn 4, Issue 12, 2015, Pages 961-970

  Quiñones, Mar ^a,b   Al Massadi, Omar ^a,b   Gallego, Rosalía ^c   Fernø, Johan ^d   Diéguez, Carlos ^a,b   López, Miguel ^a,b   Nogueiras, Ruben ^a,b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d UNIVERSITY OF BERGEN   (Norway)

Author keywords

CamKK ; Food intake; Glucagon; Hypothalamus; PKA

Indexed keywords

ADENOVIRUS VECTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE BETA; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCAGON; GLUCAGON RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NEUROPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARCUATE NUCLEUS; ARTICLE; BRAIN TISSUE; CACHEXIA; CONTROLLED STUDY; DIET INDUCED OBESITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FOOD INTAKE; HORMONAL REGULATION; HORMONE ACTION; HORMONE RESISTANCE; HORMONE SENSITIVITY; HYPERPHAGIA; HYPOTHALAMUS; HYPOTHALAMUS NUCLEUS; IN SITU HYBRIDIZATION; LEAN BODY WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84951170845     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2015.09.014     Document Type: Article

References (43)

1. Quesada I., Tuduri E., Ripoll C., Nadal A. Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes. Journal of Endocrinology 2008, 199:5-19.
2. Habegger K.M., Heppner K.M., Geary N., Bartness T.J., DiMarchi R., Tschop M.H. The metabolic actions of glucagon revisited. Nature Reviews Endocrinology 2010, 6:689-697.
3. Beale E., Andreone T., Koch S., Granner M., Granner D. Insulin and glucagon regulate cytosolic phosphoenolpyruvate carboxykinase (GTP) mRNA in rat liver. Diabetes 1984, 33:328-332.
4. Sadry S.A., Drucker D.J. Emerging combinatorial hormone therapies for the treatment of obesity and T2DM. Nature Reviews Endocrinology 2013, 9:425-433.
5. Day J.W., Ottaway N., Patterson J.T., Gelfanov V., Smiley D., Gidda J., et al. A new glucagon and GLP-1 co-agonist eliminates obesity in rodents. Nature Chemical Biology 2009, 5:749-757.
6. Clemmensen C., Chabenne J., Finan B., Sullivan L., Fischer K., Kuchler D., et al. GLP-1/glucagon coagonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet. Diabetes 2014, 63:1422-1427.
7. Finan B., Yang B., Ottaway N., Smiley D.L., Ma T., Clemmensen C., et al. A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents. Nature Medicine 2015, 21:27-36.
8. Mighiu P.I., Yue J.T., Filippi B.M., Abraham M.A., Chari M., Lam C.K., et al. Hypothalamic glucagon signaling inhibits hepatic glucose production. Nature Medicine 2013, 19:766-772.
9. Abraham M.A., Yue J.T., LaPierre M.P., Rutter G.A., Light P.E., Filippi B.M., et al. Hypothalamic glucagon signals through the KATP channels to regulate glucose production. Molecular Metabolism 2014, 3:202-208.
10. Schulman J.L., Carleton J.L., Whitney G., Whitehorn J.C. Effect of glucagon on food intake and body weight in man. Journal of Applied Physiology 1957, 11:419-421.
11. Penick S.B., Hinkle L.E. Depression of food intake induced in healthy subjects by glucagon. The New England Journal of Medicine 1961, 264:893-897.
12. Geary N., Smith G.P. Pancreatic glucagon and postprandial satiety in the rat. Physiology & Behavior 1982, 28:313-322.
13. Langhans W., Zeiger U., Scharrer E., Geary N. Stimulation of feeding in rats by intraperitoneal injection of antibodies to glucagon. Science 1982, 218:894-896.
14. Geary N., Smith G.P. Selective hepatic vagotomy blocks pancreatic glucagon's satiety effect. Physiology & Behavior 1983, 31:391-394.
15. Hell N.S., Timo-Iaria C. Increase of food intake induced by glucagon in the rat. Physiology & Behavior 1985, 34:39-44.
16. Hoosein N.M., Gurd R.S. Identification of glucagon receptors in rat brain. Proceedings of the National Academy of Sciences U S A 1984, 81:4368-4372.
17. Inokuchi A., Oomura Y., Nishimura H. Effect of intracerebroventricularly infused glucagon on feeding behavior. Physiology & Behavior 1984, 33:397-400.
18. Conarello S.L., Jiang G., Mu J., Li Z., Woods J., Zycband E., et al. Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia. Diabetologia 2007, 50:142-150.
19. Lee Y., Berglund E.D., Yu X., Wang M.Y., Evans M.R., Scherer P.E., et al. Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells. Proceedings of the National Academy of Sciences U S A 2014, 111:13217-13222.
20. Lee Y., Berglund E.D., Wang M.Y., Fu X., Yu X., Charron M.J., et al. Metabolic manifestations of insulin deficiency do not occur without glucagon action. Proceedings of the National Academy of Sciences U S A 2012, 109:14972-14976.
21. Imbernon M., Beiroa D., Vazquez M.J., Morgan D.A., Veyrat-Durebex C., Porteiro B., et al. Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/JNK1 pathways. Gastroenterology 2013, 144:636-649. e636.
22. Martinez de Morentin P.B., Gonzalez-Garcia I., Martins L., Lage R., Fernandez-Mallo D., Martinez-Sanchez N., et al. Estradiol regulates brown adipose tissue thermogenesis via hypothalamic AMPK. Cell Metabolism 2014, 20:41-53.
23. Beiroa D., Imbernon M., Gallego R., Senra A., Herranz D., Villarroya F., et al. GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK. Diabetes 2014, 63:3346-3358.
24. Komenami N., Su F.H., Thibault L. Effect of central glucagon infusion on macronutrient selection in rats. Physiology & Behavior 1996, 59:383-388.
25. Lopez M., Varela L., Vazquez M.J., Rodriguez-Cuenca S., Gonzalez C.R., Velagapudi V.R., et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nature Medicine 2010, 16:1001-1008.
26. Martinez de Morentin P.B., Whittle A.J., Ferno J., Nogueiras R., Dieguez C., Vidal-Puig A., et al. Nicotine induces negative energy balance through hypothalamic AMP-activated protein kinase. Diabetes 2012, 61:807-817.
27. Seoane L.M., Lopez M., Tovar S., Casanueva F.F., Senaris R., Dieguez C. Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus. Endocrinology 2003, 144:544-551.
28. Imbernon M., Sanchez-Rebordelo E., Gallego R., Gandara M., Lear P., Lopez M., et al. Hypothalamic KLF4 mediates leptin's effects on food intake via AgRP. Molecular Metabolism 2014, 3:441-451.
29. Charan J., Kantharia N.D. How to calculate sample size in animal studies?. Journal of Pharmacology & Pharmacotherapeutics 2013, 4:303-306.
30. Lam T.K. Neuronal regulation of homeostasis by nutrient sensing. Nature Medicine 2010, 16:392-395.
31. Lage R., Dieguez C., Vidal-Puig A., Lopez M. AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends in Molecular Medicine 2008, 14:539-549.
32. Siu F.Y., He M., de Graaf C., Han G.W., Yang D., Zhang Z., et al. Structure of the human glucagon class B G-protein-coupled receptor. Nature 2013, 499:444-449.
33. Schwoch G. Differential activation of type-I and type-II adenosine 3':5'-cyclic monophosphate-dependent protein kinases in liver of glucagon-treated rats. Biochemical Journal 1978, 170:469-477.
34. Li B., Shi Y., Shu J., Gao J., Wu P., Tang S.J. Wingless-type mammary tumor virus integration site family, member 5A (Wnt5a) regulates human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein 120 (gp120)-induced expression of pro-inflammatory cytokines via the Ca2+/calmodulin-dependent protein kinase II (CaMKII) and c-Jun N-terminal kinase (JNK) signaling pathways. The Journal of Biological Chemistry 2013, 288:13610-13619.
35. Jiao Y., Jalan-Sakrikar N., Robison A.J., Baucum A.J., Bass M.A., Colbran R.J. Characterization of a central Ca2+/calmodulin-dependent protein kinase IIalpha/beta binding domain in densin that selectively modulates glutamate receptor subunit phosphorylation. The Journal of Biological Chemistry 2011, 286:24806-24818.
36. Pocai A., Carrington P.E., Adams J.R., Wright M., Eiermann G., Zhu L., et al. Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice. Diabetes 2009, 58:2258-2266.
37. Damm E., Buech T.R., Gudermann T., Breit A. Melanocortin-induced PKA activation inhibits AMPK activity via ERK-1/2 and LKB-1 in hypothalamic GT1-7 cells. Molecular Endocrinology 2012, 26:643-654.
38. Aw D.K., Sinha R.A., Xie S.Y., Yen P.M. Differential AMPK phosphorylation by glucagon and metformin regulates insulin signaling in human hepatic cells. Biochemical and Biophysical Research Communications 2014, 447:569-573.
39. Chen M., Gavrilova O., Zhao W.Q., Nguyen A., Lorenzo J., Shen L., et al. Increased glucose tolerance and reduced adiposity in the absence of fasting hypoglycemia in mice with liver-specific Gs alpha deficiency. Journal of Clinical Investigation 2005, 115:3217-3227.
40. Norrelund H., Wiggers H., Halbirk M., Frystyk J., Flyvbjerg A., Botker H.E., et al. Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure. Journal of Internal Medicine 2006, 260:11-21.
41. Campos C.A., Shiina H., Ritter R.C. Central vagal afferent endings mediate reduction of food intake by melanocortin-3/4 receptor agonist. Journal of Neuroscience 2014, 34:12636-12645.
42. Gillard E.R., Khan A.M., Mouradi B., Nalamwar O., Stanley B.G. Eating induced by perifornical cAMP is behaviorally selective and involves protein kinase activity. American Journal of Physiology 1998, 275:R647-R653.
43. Anderson K.A., Ribar T.J., Lin F., Noeldner P.K., Green M.F., Muehlbauer M.J., et al. Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metabolism 2008, 7:377-388.